Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis.
Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M. Maran A, et al. Among authors: giorgino f, giorgino r. Diabetes Care. 2002 Feb;25(2):347-52. doi: 10.2337/diacare.25.2.347. Diabetes Care. 2002. PMID: 11815508 Clinical Trial.
Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.
Laviola L, Perrini S, Cignarelli A, Natalicchio A, Leonardini A, De Stefano F, Cuscito M, De Fazio M, Memeo V, Neri V, Cignarelli M, Giorgino R, Giorgino F. Laviola L, et al. Among authors: giorgino f, giorgino r. Diabetes. 2006 Apr;55(4):952-61. doi: 10.2337/diabetes.55.04.06.db05-1414. Diabetes. 2006. PMID: 16567516 Free article.
The IGF-I signaling pathway.
Laviola L, Natalicchio A, Giorgino F. Laviola L, et al. Among authors: giorgino f. Curr Pharm Des. 2007;13(7):663-9. doi: 10.2174/138161207780249146. Curr Pharm Des. 2007. PMID: 17346182 Review.
Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.
Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E, Bosi E, Buzzetti R; Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group. Lampasona V, et al. Among authors: giorgino f. Diabetes Care. 2010 Jan;33(1):104-8. doi: 10.2337/dc08-2305. Epub 2009 Oct 6. Diabetes Care. 2010. PMID: 19808923 Free PMC article.
Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR study: similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction.
Nicolucci A, Del Prato S, Vespasiani G; ELEONOR Study Group. Nicolucci A, et al. Diabetes Care. 2011 Dec;34(12):2524-6. doi: 10.2337/dc11-0900. Epub 2011 Sep 27. Diabetes Care. 2011. PMID: 21953799 Free PMC article. Clinical Trial.
Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention.
Scavini M, Bosi E, Ceriello A, Giorgino F, Porta M, Tiengo A, Vespasiani G, Bottalico D, Marino R, Parkin C, Bonizzoni E, Cucinotta D. Scavini M, et al. Among authors: giorgino f. Acta Diabetol. 2013 Oct;50(5):663-72. doi: 10.1007/s00592-011-0357-y. Epub 2011 Dec 22. Acta Diabetol. 2013. PMID: 22189755 Free PMC article. Clinical Trial.
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance.
Bianchi C, Miccoli R, Bonadonna RC, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo GM, Leonetti F, Del Prato S; GENFIEV Investigators. Bianchi C, et al. Among authors: giorgino f. Diabetes Care. 2012 Dec;35(12):2607-12. doi: 10.2337/dc11-2504. Epub 2012 Aug 21. Diabetes Care. 2012. PMID: 22912427 Free PMC article.
366 results